Clinical Trials Browser

INDUSTRY × surufatinib × Other solid neoplasm × Clear all

NCT04169672 2023-03-02

Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors

Phase 2 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT04427774 2021-07-20

A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor

Phase 1 Terminated

Other solid neoplasm

Advanced or Metastatic Solid Tumors